Presto Automation Announces Fiscal Third Quarter 2024 Financial Results
May 21, 2024 01:10 ET
|
Presto Automation Inc.
Presto Automation Announces Fiscal Third Quarter 2024 Financial Results
Litchfield Hills Research reiterates buy recommendation at $10.00 per share
May 21, 2024 01:10 ET
|
VIRTUALWARE 2007 SA
New York and Bilbao, Spain, 21 May - US equity research firm Litchfield Hills Research has just published a new analysis of Virtualware (ENXTPA: MLVIR), reiterating its Buy...
DNO to Hold Fixed Income Investor Meetings
May 21, 2024 01:00 ET
|
DNO ASA
Oslo, 21 May 2024 – DNO ASA, the Norwegian oil and gas operator, today announced it has engaged DNB Markets, part of DNB Bank ASA, and Pareto Securities AS as Global Coordinators and Joint Bookrunners...
Start of Day Message
May 21, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 21 May. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
May 21, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board – taking...
FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
May 21, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the...
Planisware - Q1 2024 revenue - Strong start of the year and dynamic commercial momentum
May 21, 2024 01:00 ET
|
Planisware
Q1 2024 revenue Strong start of the year anddynamic commercial momentum Total revenue growth of +19.6% in constant currencies, reaching € 40.9 millionSolid commercial traction with existing clients...
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
May 21, 2024 01:00 ET
|
VALNEVA
Saint-Herblain (France), May 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief...
Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor
May 21, 2024 00:50 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – May 21, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024. Business highlights ...
Idorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable value
May 21, 2024 00:40 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – May 21, 2024Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year of 2023. Business highlights Sale of...